期刊文献+

鲍曼不动杆菌外膜蛋白研究进展 被引量:4

Study on outer membrane proteins of Aeinetobacter baumannii
原文传递
导出
摘要 鲍曼不动杆菌是医院获得性感染主要致病菌之一,其外膜蛋白是指肽聚糖外脂质双层中间镶嵌的一些特殊的蛋白质。CarO、33-to-36-kDa、OprD等外膜蛋白丢失与细菌耐药有关,而OmpA外膜蛋白是重要的致病因素。其研究技术分为提取、分离和鉴定3个方面,超声物理法、双向凝胶电泳、质谱技术及免疫印迹是目前常用技术。 Acinetobaeter baumannii is one of the major pathogens in nosocomial infection, its outer membrane proteins are some special proteins embedded in lipid bilayer outside the peptidoglycan. The loss of CarO,33-to36-kDa, OprD and other outer membrane proteins is related with drug resistance, and outer membrane protein A is an important pathogenic factor. Its research technology including three aspects of the extraction, separation and identification, the ultrasound physical method, 2-Dimensional Gel Electrophoresis, mass spectrometry and western blot analysis are commonly used now.
出处 《国际呼吸杂志》 2011年第19期1512-1515,共4页 International Journal of Respiration
关键词 鲍曼不动杆菌 外膜蛋白 技术 Acinetobacter baumannii Outer membrane protein Technology
  • 相关文献

参考文献30

  • 1Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis, 2008,46 : 1254-1263.
  • 2Peleg AY, Seifert H, Paterson DI.. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev,2008,21:538-582.
  • 3Higgins PG, Dammhayn C, Hackel M,et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother, 2010,65 : 233-238.
  • 4Dijkshoorn L, Nemec A, Seifcrt H. An increasing threat in hospitals: multidrug-resistant Acinetobaeter baumannii. Nat Rev Microbiol,2007,5:939-951.
  • 5Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with heahhcare-assoeiated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006 2007. Infect Control Hosp Epidemiol,2008,29:996-1011.
  • 6汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 7Chen MZ, Hsueh PR, Lee I.N, et al. Severe community acquired pneumonia due to Acinetobacter baumannii. Chest, 2001,120: 1072-1077.
  • 8Telang NV, Satpute MG, Dhakephalkar PK, et al. Fulminating septicemia due to persistent pan resistant community-acquired metallo-β-laetamase (IMP-1) positive Acinetobacter baumannii. Indian J Pathol Microbiol, 2011,54 : 180 182.
  • 9Mussi MA, Limansky AS, Viale AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta barrel outer membrane proteins. Antimicrob AgenIs Chemother,2005,49:1432-1440.
  • 10Siroy A, Molle V, I.ema? trc-Guillier C, et al. Channel formation by CarO, the carbapenem resistance associated outer membrane protein of Acinetohacter baumannii. Antimicrob Agents Chemother, 2005,49 : 4876-4883.

二级参考文献16

  • 1Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 2Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
  • 3Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
  • 4Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
  • 5Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
  • 6Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
  • 7Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25.
  • 8Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature[J]. Clin Infent Dis, 2009,49(2):271-274.
  • 9Pachon Ibanez ME, Jimenez Mejias ME, Pichardo C, et al Activity of tigeeyeline (GAR 936) against Acinetobacter bau mannii strains, including those resistant to imipenem[J] Antimicrob Agents Chemother, 2004,48 ( 11 ):4479-4481.
  • 10Stein GE, Craig WA. Tigecycline: a critical analysis[J]. Clin Infent Dis, 2006, 43(4):518-524.

共引文献396

同被引文献55

  • 1Vashist J, Tiwari V, Kapil A, et al. Quantitative profiling and identification of outer membrane proteins of 13-1actam resistant strain of acinetobacter baumannii [ J ]. J Proteome Res,2010;9( 2 ) :1121-1128.
  • 2Fernando DM, Xu W, Loewen PC, et al. Triclosan can select for an adeijk-overexpressing mutant of acinetobacter baumannii atcc 17978 that displays reduced susceptibility to multiple antibiotics [ J ]. Antimicrob Agents Chemother, 2014 ;58( 11 ) :6424-6431.
  • 3Srinivasan VB, Vaidyanathan V, Rajamohan G. Abuo, A tolc- like outer membrane protein of acinetobacter baumannii, Is involved in antimicrobial and oxidative stress resistance [ J ]. A ntimicrob Agents Chemother,2015 ;59 ( 2 ) : 1236-1245.
  • 4Richards AM, Abu kwaik Y, Lamont RJ. Code blue: acinetobacter baumannii, A nosocomial pathogen with a role in the oral cavity [ J ]. Mol Oral Microbiol, 2015 ; 30 ( 1 ) : 12-15.
  • 5Fiester SE, Nwugo CC, Penwell WF, et al. Role of the carboxyl terminus of seca in iron acquisition, Protein translocation and virulence of the bacterial pathogen acinetobacter baumannii [ J ]. Infect Immun,2015 ;20 (42) : 5-14.
  • 6Choi CH, Lee JS, Lee YC, et al. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells [ J ]. BMC Microbiol,2008 ;8 ( 1 ) :1-11.
  • 7Doi Y, Murray GL, Peleg AY. Aeinetobacter baumannii: evolution of antimicrobial resistance- treatment options [J]. Semin Respir Grit Care Med,2015 ;36(1) :85-98.
  • 8Rumbo C, Tom6s M, Fern6ndez moreira E, et al. The acinetobacter baumannii omp 33-36porin is a virulence factor that induces apoptosis and modulates autophagy in human cells [ J]. Infect Immun, 2014; 82 ( 11 ): 4666 -4680.
  • 9Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria [ J ]. Front Microbiol, 2014 ; 5 : 643.
  • 10Moffatt JH, Harper M, Harrison P, et al. Colistin resistance in acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production [ J ]. Antimicrob Agents Chemother, 2010 ;54 ( l 2 ) :4971-4977.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部